• AGA Clinical Practice Update: Pause IBD Meds For Patients With COVID-19

AGA Clinical Practice Update: Pause IBD Meds For Patients With COVID-19

Patients with inflammatory bowel diseases (IBD) with COVID-19 should delay biological therapies, restarting them once symptoms are gone, says a clinical practice update from the American Gastroenterological Association (AGA). The practice update, written by David T Rubin et al, says that patients with IBD who test positive for SARS-CoV-2 but

Read more
  • REVIEW: All About Gastric (Stomach) Cancer

REVIEW: All About Gastric (Stomach) Cancer

Despite the worldwide decrease in gastric cancer incidence and mortality over the past 5 decades, it is still the third-leading cause of cancer-related death. Understanding the epidemiology and risk factors for gastric cancer can aide in determination of risk, screening, and prevention. In the March issue of Clinical Gastroenterology and

Read more
  • Gastroparesis Caused by Hepatitis A Virus Infection

Gastroparesis Caused by Hepatitis A Virus Infection

Researchers describe a rare case of infectious gastroparesis caused by hepatitis A virus infection in the December issue of Gastroenterology. Amrit K. Kamboj et al report the case of a 33-year-old woman with a 10-day history of painless jaundice, decreased appetite, malaise, and pruritus. The patient did not have right

Read more
  • Is it Cost Effective to Transplant HCV-positive Livers Into HCV-negative Patients?

Is it Cost Effective to Transplant HCV-positive Livers Into HCV-negative Patients?

A Markov-based mathematical model estimates that transplanting hepatitis C virus (HCV)-positive livers into HCV-negative patients who have received direct-acting antiviral (DAA) agents would be cost effective and improve outcomes, researchers report in the March issue of Clinical Gastroenterology and Hepatology. There has been a steady increase in the number of

Read more
  • Does Colony Stimulating Factor Increase Survival of Patients with Alcoholic Hepatitis?

Does Colony Stimulating Factor Increase Survival of Patients with Alcoholic Hepatitis?

In a pilot study from the October issue of Clinical Gastroenterology and Hepatology, colony stimulating factor 3 (CSF3, also called GCSF) improved liver function and increased survival times in patients with severe alcohol-associated hepatitis (AH), compared with standard therapy. Addition of N-acetyl cysteine (NAC) to GCSF did not improve patient outcomes. Patients

Read more

A Parasitic Infection From Sashimi

Researchers report a case of anisakiasis, caused by nematodes of the genus Anisakis—a parasite transmitted to humans through raw seafood such as sushi and sashimi. In the May issue of Gastroenterology, Kaori Ikegami et al describe the case of a 47-year-old man who arrived at the emergency department with severe epigastric pain.

Read more
  • Hookworms Cause GI Bleeding

Hookworms Cause GI Bleeding

Hookworms, although uncommon, are an important cause of gastrointestinal bleeding in patients of all ages, researchers remind readers in the November issue of Clinical Gastroenterology and Hepatology. Puneet Chhabra and Deepak K. Bhasin describe the case of a 72-year-old man with Parkinson disease who presented with fatigue, dyspnea on exertion, and

Read more

Gastrointestinal Bleeding Caused by Gastric Tuberculosis

Researchers describe a case of gastric tuberculosis that led to GI bleeding in the June issue of Clinical Gastroenterology and Hepatology. Vishal Sharma et al report that a 30-year-old man who was a resident of North India presented to emergency services with 2 episodes of painless hematemesis. He did not have a history of

Read more
  • What are the Effects of Prednisolone in Patients With Severe Alcoholic Liver Disease?

What are the Effects of Prednisolone in Patients With Severe Alcoholic Liver Disease?

Infections are frequent in patients with severe alcoholic liver disease, but are only independently associated with mortality when patients receive prednisolone, researchers report in the April issue of Gastroenterology. This could offset prednisolone’s therapeutic benefit. This study’s senior author, Mark Thursz, discusses the findings in a video abstract. As with

Read more
  • Does Good Oral Health Increase Risk for IBD?

Does Good Oral Health Increase Risk for IBD?

A population-based cohort study of more than 20,000 people in Sweden associated poor oral health with reduced risk for inflammatory bowel diseases (IBD). The article, in the April issue of Clinical Gastroenterology and Hepatology, reports that the protective effect increases with the severity of poor dental hygiene. Environmental factors, such as

Read more